These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39008643)

  • 21. Prognostic Value of Venous Invasion Detected by Elastin Stain May Surpass Lymph Node Status in Colon Cancer.
    Kim HJ; Choi GS; Seo AN; Park JS; Park SY; Cho SH; Yoon G
    Dis Colon Rectum; 2021 Aug; 64(8):955-963. PubMed ID: 33938533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer.
    Luo YH; Yan ZC; Liu JY; Li XY; Yang M; Fan J; Huang B; Ma CG; Chang XN; Nie X
    World J Gastroenterol; 2024 Jan; 30(2):158-169. PubMed ID: 38312121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of tumor budding in colorectal carcinoma: correlation with β-catenin nuclear expression.
    El-Gendi S; Al-Gendi A
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):1-9. PubMed ID: 22099930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prognostic model to predict survival in stage III colon cancer patients based on histological grade, preoperative carcinoembryonic antigen level and the neutrophil lymphocyte ratio.
    Wuxiao ZJ; Zhou HY; Wang KF; Chen XQ; Hao XB; Lu YD; Xia ZJ
    Asian Pac J Cancer Prev; 2015; 16(2):747-51. PubMed ID: 25684519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
    Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
    Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?
    Archilla I; Díaz-Mercedes S; Aguirre JJ; Tarragona J; Machado I; Rodrigo MT; Lopez-Prades S; Gorostiaga I; Landolfi S; Alén BO; Balaguer F; Castells A; Camps J; Cuatrecasas M
    Clin Transl Gastroenterol; 2021 Mar; 12(3):e00303. PubMed ID: 33939382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of preoperative fibrinogen in patients with colon cancer.
    Sun ZQ; Han XN; Wang HJ; Tang Y; Zhao ZL; Qu YL; Xu RW; Liu YY; Yu XB
    World J Gastroenterol; 2014 Jul; 20(26):8583-91. PubMed ID: 25024612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
    Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
    Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a combination of CEA and tumor budding to identify high-risk patients with stage II colon cancer.
    Du C; Xue W; Dou F; Peng Y; Yao Y; Zhao J; Gu J
    Int J Biol Markers; 2017 Jul; 32(3):e267-e273. PubMed ID: 28478638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer.
    Sundov Z; Tomic S; Alfirevic S; Sundov A; Capkun V; Nincevic Z; Nincevic J; Kunac N; Kontic M; Poljak N; Druzijanic N
    Hepatogastroenterology; 2013 May; 60(123):432-8. PubMed ID: 23321007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
    Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
    Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor budding in infiltrating breast carcinoma: Correlation with known clinicopathological parameters and hormone receptor status.
    Agarwal R; Khurana N; Singh T; Agarwal PN
    Indian J Pathol Microbiol; 2019; 62(2):222-225. PubMed ID: 30971544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
    PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lumican and versican are associated with good outcome in stage II and III colon cancer.
    de Wit M; Belt EJ; Delis-van Diemen PM; Carvalho B; Coupé VM; Stockmann HB; Bril H; Beliën JA; Fijneman RJ; Meijer GA
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S348-59. PubMed ID: 22711178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Grading of tumor budding in intestinal-type early gastric adenocarcinoma and its role in assessing the risk of lymph node metastasis].
    Zhou ZY; Guo Q; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):779-784. PubMed ID: 34405614
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
    Basile D; Broudin C; Emile JF; Falcoz A; Pagès F; Mineur L; Bennouna J; Louvet C; Artru P; Fratte S; Ghiringhelli F; André T; Derangère V; Vernerey D; Taieb J; Svrcek M;
    Ann Oncol; 2022 Jun; 33(6):628-637. PubMed ID: 35306156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
    Özaslan E; Demir S; Karaca H; Güven K
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
    Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
    Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.